219 Aruni B, Sharifian A, Eryazici P, Herrera CJ Late bacterial endocarditis of an amplatzer atrial septal device Indian Heart J 2013;65:450–451 220 Kim DJ, Shim CY, You SC, Lee SH, Hong GR Late bacterial endocarditis and abscess formation after implantation of an amplatzer septal occluder device Circulation 2015;131:e536–e538 221 Thibodeau-Jarry N, Ibrahim R, Ducharme A, Sia YT Late infection of an atrial septal defect closure device: a possible complication Can J Cardiol 2015;31:1204.e9–1204.e11 222 Walpot J, Amsel B, Rodrigus I, et al Late infective endocarditis of an atrial septal occluder device presenting as a cystic mass Echocardiography 2011;28(6):E131–E133 223 Amedro P, Soulatges C, Fraisse A Infective endocarditis after device closure of atrial septal defects: case report and review of the literature Catheter Cardiovasc Interv 2016 224 Jha NK, Kiraly L, Murala JS, et al Late endocarditis of amplatzer atrial septal occluder device in a child World J Cardiol 2015;7(10):703–706 225 Sandoe JA, Barlow G, Chambers JB, et al Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection Report of a joint working party project on behalf of the British society for antimicrobial chemotherapy (BSAC, host organization), British heart rhythm society (BHRS), British cardiovascular society (BCS), British heart valve society (BHVS) and British society for echocardiography (BSE) J Antimicrob Chemother 2015;70(2):325–359 226 Carrasco F, Anguita M, Ruiz M, et al Clinical features and changes in epidemiology of infective endocarditis on pacemaker devices over a 27-year period (1987-2013) Europace 2016;18(6):836–841 227 Johansen JB, Jorgensen OD, Moller M, et al Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients Eur Heart J 2011;32:991– 998 228 Voigt A, Shalaby A, Saba S Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights Pacing Clin Electrophysiol 2010;33:414–419 229 Cunningham D, Charles R, Cunningham M, et al Cardiac Rhythm Management: UK National Clinical Audit 2010 http://www.hqip.org.uk/assets/NCAPOPLibrary/CRM-2011-National-Clinical-AuditReport-2010.pdf; 2011 230 Klug D, Lacroix D, Savoye C, et al Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management Circulation 1997;95:2098–2107 231 Welch M, Uslan DZ, Greenspon AJ, et al Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections Pacing Clin Electrophysiol 2014;37(8):955–962 232 Golzio PG, Fanelli AL, Vinci M, et al Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects Europace 2013;15:89–100 233 Greenspon AJ, Le KY, Prutkin JM, et al Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry JACC Cardiovasc Imaging 2014;7(6):541–549 234 Victor F, de Place C, Camus C, et al Pacemaker lead infection: echocardiographic features, management, and outcome Heart 1999;81:82– 87 235 Klug D, Balde M, Pavin D, et al Risk factors